Phase
Condition
Liver Disease
Treatment
N/AClinical Study ID
Ages 18-80 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Biopsy proven NASH
If suffering from diabetes may be treated by up to 2 oral medications, with stabledoses for 2 months.
If participating in sexual activity that could lead to pregnancy, the study volunteermust agree that two reliable methods of contraception will be used simultaneouslywhile receiving the protocol-specified medication and for 1 month after stopping themedication. NOTE: Hormonal-based methods alone are not sufficient. At least two of the followingmethods MUST be used appropriately unless documentation of menopause, sterilization,or azoospermia is present:
Condoms (male or female) with or without a spermicidal agent. - Condoms arerecommended because their appropriate use is the only contraception methodeffective for preventing HIV transmission
Diaphragm or cervical cap with spermicide
IUD
Hormonal-based contraception Study subjects who are not of reproductive potential (girls who have not reachedmenarche or women who have been post-menopausal for at least 24 consecutive months orhave undergone hysterectomy and/or bilateral oophorectomy are eligible withoutrequiring the use of contraceptives. Written or oral documentation communicated byclinician or clinician's staff is required by one of the following:
Physician report/letter
Operative report or other source documentation in the patient record (alaboratory report of azoospermia is required to document successful vasectomy)
Discharge summary
Laboratory report of azoospermia
FSH measurement elevated into the menopausal range as established by thereporting laboratory.
- Ability and willingness of subject or legal guardian/representative to provideinformed consent.
Exclusion
Exclusion Criteria:
Pregnancy or Breast-Feeding
Continuous use of the following medications for more than 3 days within 30 days ofstudy entry:
Immunosuppressives
Immune modulators
Systemic glucocorticoids
Anti-neoplastic agents
Active drug or alcohol use or dependence that, in the opinion of the siteinvestigator, would interfere with adherence to study requirements.
Serious illness requiring systemic treatment and/or hospitalization within 30 daysprior to entry.
Surgery within the previous 3 months.
Any serious infectious, cardiac, pulmonary, or kidney disease
Hypersensitivity to Femarelle ®
Malignancy of the uterus or breast
Past thromboembolic event
Study Design
Connect with a study center
Hadassah Medical Organization, Jerusalem, Israel
Jerusalem, 91120
IsraelSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.